EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents

Puhua Wu, Zhicheng Zhang, Yan Zhou, Quan Liu, Kin-Yip Tam, Zhenhong Su

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s473437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Puhua Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, School of Medicine, Hubei Polytechnic University, Huangshi, People's Republic …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Acetophenones, Drug Screening Assays, Antitumor, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAcetophenonesDrug Screening Assays, AntitumorPyruvate Dehydrogenase Acetyl-Transferring KinaseDose-Response Relationship, DrugHumansAnimalsStructure-Activity RelationshipMiceMolecular StructureCell ProliferationProtein Kinase InhibitorsLung NeoplasmsProtein Serine-Threonine KinasesMice, NudeModels, MolecularCarcinoma, Non-Small-Cell LungNeoplasms, ExperimentalCell Line, TumorMice, Inbred BALB C

Stichwörter der Autor:innen

PDHK1allosteric pocketanti-NSCLC activitydichloroacetophenonetumor xenograft mouse model

Substanzen

Antineoplastic AgentsAcetophenonesPyruvate Dehydrogenase Acetyl-Transferring KinaseProtein Kinase InhibitorsProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, School of Medicine, Hubei Polytechnic University, Huangshi, People's Republic of China.
  • Cancer Centre, Faculty of Health Sciences, University of Macau, Macau, People's Republic of China.

Zitieren

APA

Wu, P., Zhang, Z., Zhou, Y., Liu, Q., Tam, K. Y., & Su, Z. (2024). Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s473437

Vancouver

Wu P, Zhang Z, Zhou Y, Liu Q, Tam KY, Su Z. Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s473437

BibTeX
@article{Wu2024,
  author = {Wu, Puhua and Zhang, Zhicheng and Zhou, Yan and Liu, Quan and Tam, Kin-Yip and Su, Zhenhong},
  title = {Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s473437}
}
Kostenlos starten →